SCHEMBL13459571

SCHEMBL13459571

O=C(Nc1ccc(Oc2ccccc2)cc1)Nc1ccc(-c2cccc3cnccc23)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 3/20 0.51
▸ NAMPT P43490 1/20 0.50
▸ TRPV1 Q8NER1 3/20 0.49
▸ RAF1 P04049 2/20 0.49
▸ BTK Q06187 1/20 0.48
▸ CYP3A4 P08684 1/20 0.47
▸ CYP3A5 P20815 1/20 0.47
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ BRAF P15056 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ TNNI3K Q59H18 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459817 0.81 TRPV1 (0.53) IMPDH2TRPV1CYP3A4CYP3A5KDR
SCHEMBL13459539 0.78 EGFR (0.60) TRPV1BRAFKDRALDH1A1MAPT
SCHEMBL13459599 0.78 POLB (0.60) NAMPTTRPV1ALDH1A1LMNAMAPT
SCHEMBL13459838 0.77 MEN1 (0.55) IMPDH2TRPV1CYP3A4CA12CA1
SCHEMBL13632604 0.77 KDR (0.59) TRPV1CA12CA1CA2CA9
SCHEMBL13459594 0.77 HTR2B (0.53) IMPDH2TRPV1CYP3A4CYP3A5KDR
SCHEMBL13459598 0.76 CYP17A1 (0.54) NAMPTTRPV1KDRALDH1A1LMNA
SCHEMBL13459834 0.75 CYP3A4 (0.58) NAMPTTRPV1CYP3A4CYP3A5CA12
SCHEMBL13459592 0.75 RIPK1 (0.69) TRPV1KDR
SCHEMBL12074747 0.74 TNF (0.69) CYP3A4CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback